Michael is an accomplished life science CFO with more than 20 years of experience in the UK and US markets and in all stages of development, from discovery through commercialization. He has led numerous IPO and financing transactions and built and scaled infrastructure to enable commercial success. He holds a Masters in Finance from London Business School.
Select Achievements
- Scaled a clinical development platform company from four to 14 legal entities across four countries, moving from preclinical to first in human trials while coordinating fundraising through Series B to IPO in 18 months
- Established operational support (Finance, HR, IT) for gene therapy startup, working through seed to Series A stage